Intriguingly, independent of BMI or specific RA therapy, such as the use of glucocorticoids, higher baseline disease activity and elevated levels of pro-inflammatory cytokines, including IL-1 and IL-6, are associated with a significantly higher risk of incident DM in RA patients [36]. This evidence concerns the gene IL6 and rheumatoid arthritis.